Trial Profile
A efficacy trial of sorafenib in Patients With Pulmonary metastatic hepatocellular carcinoma after liver transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 12 Dec 2015 New trial record